HDFC Life s Q4FY25 performance is anticipated to show strong growth, with brokerages projecting a 10-17% YoY increase in annualised premium equivalent (APE), potentially reaching ₹5,510 crore. The value of new business (VNB) is also expected to rise by 10-14%. Sharekhan estimates a 31% YoY surge in profit after tax, while Nuvama is most bullish on APE and VNB growth.

Indian benchmark equity indices opened lower on Thursday, weighed down by IT stocks following Wipro s revenue decline forecast amid tariff concerns. The BSE Sensex fell by 0.39%, and the Nifty50 slipped by 0.49%. This downturn was further influenced by US Federal Reserve Chair Jerome Powell s warning about the risks of tariffs on growth and prices.

Amidst market volatility triggered by Donald Trump s policy shifts, Indian investors are navigating uncertainty in 2024. Experts advise a diversified risk management strategy, emphasizing long-term investments in sectors like cement, infrastructure, and rural consumption, which are less sensitive to global events. Defensive sectors and diversified conglomerates offer stability.

Pushkar Singh, an ETNow viewer, aims to accumulate ₹75 lakh to ₹1 crore in a decade through SIPs. While his current investments in funds like SBI and Parag Parikh are well-chosen, experts advise increasing his monthly SIP amount significantly, potentially starting at ₹30,000 and escalating by 10% annually, to realistically achieve his ambitious financial goal.

HDFC Securities has issued a reduce call on Max Healthcare, setting a target price of Rs 1020, while the current market price is Rs 1080.85. Max Healthcare reported a consolidated total income of Rs 1901.61 crore for the quarter ended December 31, 2024, a 37.70% increase from the previous year.

Wipro’s earnings miss and muted guidance had a ripple effect across the IT sector, dragging down peer stocks. Infosys shares slipped 1.6% ahead of its earnings announcement later in the day. LTIMindtree, HCL Technologies, and Mphasis declined between 3% and 3.4%, while Tech Mahindra, Coforge, and Persistent Systems fell between 2% and 2.4%

There is enough uncertainty that I do not think we can say the bottom is in the markets. What we saw is that President Trump reacted not to equity markets, but to the bond markets.

Vedanta led NSE 100 s FY25 performance with an 87% TSR, driven by share price appreciation and dividends. Divi’s Laboratories, Bajaj Holdings, BEL, and IndiGo also delivered strong returns. Vedanta s growth was fueled by a strengthened balance sheet, production efficiencies, and progress on its demerger plan, enhancing investor confidence.

Gensol Engineering shares hit a fresh 52-week low, down 90% from peak, after Sebi barred its promoters for financial misconduct and governance lapses. The probe revealed fund diversion of over Rs 977 crore, falsified documents, and luxury spending. Gensol has pledged full cooperation with a forensic audit as investor sentiment remains deeply impacted.